Skip to main content
Full access
Departments
Published Online: 1 April 2014

Citalopram in Agitated and Delusional Demented Patients Who Failed Treatment With Antipsychotic Agents

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
To the Editor: Agitation is a common, difficult to treat complication of dementing disorders. Optimal management of agitation consists of treatment of precipitants of agitation, including undiagnosed medical problems, pain, drug toxicity, environmental triggers, poor sleep, delirium, and depression.1 When precipitants of agitation are either absent or successfully treated, pharmacological treatment may target the syndrome of agitation. Antipsychotic agents are recommended as the first line treatment for this purpose. However, antipsychotic drugs have modest efficacy2 and entail safety concerns including orthostasis, drowsiness, extrapyramidal syndromes, incoordination, metabolic syndrome, prolonged QTc in EKG, and cerebrovascular events.3
Antidepressants have received limited attention in the treatment of agitation of dementia. A controlled trial of demented patients psychiatrically hospitalized for agitation showed that citalopram and perphenazine were superior to placebo and found no difference in the efficacy of the two psychotropic agents.4 A more recent study showed that citalopram had equal efficacy with risperidone in demented patients who required psychiatric inpatient care because of agitation.5
We recently successfully treated with citalopram two agitated, delusional, nondepressed, demented patients who had failed several trials of antipsychotics. Our first patient was an 84-year-old woman with a mixed Alzheimer’s/vascular dementia who was acutely hospitalized because of physical aggression and the somatic delusion that her organs were being moved around in her body. Trials of risperidone, haloperidol, and quetiapine led to equivalent response, while lorazepam worsened her agitation. On admission, risperidone was replaced with citalopram 10 mg twice daily and increased to 15 mg twice daily. Within 72 hours, the agitation diminished dramatically, and the patient was discharged soon thereafter. On follow-up several weeks after discharge, we found that she remained in good behavioral control.
The second patient was an 80-year-old woman with Alzheimer’s dementia who presented with violent behavior and paranoia. She had failed trials of atypical and typical antipsychotics. She was initially treated with risperidone but showed no improvement. She was switched to citalopram 10 mg twice daily, which was later increased to 15 mg twice daily. Her agitation and paranoia improved 4 days after starting citalopram and remained agitation free throughout the hospitalization and several weeks after discharge.
What is interesting about the above cases is that citalopram reduced agitation in nondepressed, demented patients with delusions and paranoia. Combined with earlier studies, this observation suggests that citalopram may be a reasonable treatment option for nondepressed, delusional, agitated, demented patients that do not share the side effects of antipsychotic agents.

References

1.
Salzman C, Jeste DV, Meyer RE, et al.: Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy. J Clin Psychiatry 2008; 69:889–898
2.
Sink KM, Holden KF, Yaffe K: Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA 2005; 293:596–608
3.
Steinberg M, Lyketsos CG: Atypical antipsychotic use in patients with dementia: managing safety concerns. Am J Psychiatry 2012; 169:900–906
4.
Pollock BG, Mulsant BH, Rosen J, et al.: Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients. Am J Psychiatry 2002; 159:460–465
5.
Pollock BG, Mulsant BH, Rosen J, et al.: A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia. Am J Geriatr Psychiatry 2007; 15:942–952

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: E62
PubMed: 24763800

History

Published online: 1 April 2014
Published in print: Spring 2014

Authors

Details

Nabil Kotbi, M.D.
Department of Psychiatry, Weill Cornell Medical College, New York-Presbyterian Hospital, White Plains, NY
Arun Singh, D.O.
Department of Psychiatry, Weill Cornell Medical College, New York-Presbyterian Hospital, White Plains, NY
Jerard Kneifati-Hayek, B.A.
Department of Psychiatry, Weill Cornell Medical College, New York-Presbyterian Hospital, White Plains, NY
Anna Odom, Ph.D.
Department of Psychiatry, Weill Cornell Medical College, New York-Presbyterian Hospital, White Plains, NY
George Alexopoulos, M.D.
Department of Psychiatry, Weill Cornell Medical College, New York-Presbyterian Hospital, White Plains, NY

Notes

Send correspondence to Dr. Odom; e-mail: [email protected]

Competing Interests

Dr. Alexopoulos has received grant support from Forest; he has served as a consultant to Forest, Hoffman-La Roche, Janssen, Lilly, Lundbeck, Pfizer, and Otsuka; and he currently serves or has served on the speakers' bureau of AstraZeneca, Avanir, Forest, Merck, Novartis, Sunovion, and Takeda-Lundbeck. All other authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share